The effect of vitamin D on the humoral immune response of calves to sheeppox virus vaccine

Document Type : Original Articles

Authors

1 Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

2 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.

3 Department of Animal Viral Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension organization, Karaj, Iran

4 Department of Pathobiology, Faculty of Veterinary Medicine, Shahrekord University, Shhrekord, Iran.

10.22092/ari.2025.369110.3611

Abstract

Although the efficacy of the vaccine is influenced by various factors, including vitamin D levels, studies in this field have yielded different results. Vaccination with attenuated sheeppox virus vaccine (RM/65) remains a preventive strategy in countries where lumpy skin disease (LSD) is prevalent,but there is no evidence from experimental research on the effect of vitamin D on the immune response to this vaccine for the prevention of lumpy skin disease. For this purpose, twenty calves were selected and divided into four groups. To ensure that calves had different baseline levels of vitamin D, they were divided into two groups. One group was exposed to sunlight, while the other two groups was kept in the shade. Each of these groups was further divided into two treatment groups: one receiving vitamin D (Cholecalciferol) injections and the other a control group. All groups received an attenuated sheeppox virus vaccine (RM/65), while only two groups received vitamin D simultaneously with the vaccine. Blood samples were collected from each calf weekly for six weeks. Sheeppox virus antibodies were measured according to the WOAH (or OIE) protocol, with a neutralization index (NI) titer of ≥1.5 international units considered protective. Statistical analysis revealed a significant increase in sheeppox virus antibody levels within individual groups after day 21 (P ≤ 0.01). However, no significant differences were observed between the four groups beyond this time point. Consequently, antibody levels in the groups receiving vitamin D did not differ from those in the other groups. These findings are consistent with previous studies, indicating that vitamin D supplementation does not affect the efficacy of the vaccine.

Keywords

Main Subjects